OpGen Inc Financials

OpGen Stock Summary

OpGen competes with Bone Biologics, NanoVibronix, Bluejay Diagnostics, Vivos Therapeutics, and Tivic Health. OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. The company was incorporated in 2001 and is headquartered in Rockville, Maryland. Opgen operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 91 people.

OpGen Key Financial Ratios

OpGen's financial ratios allow both analysts and investors to convert raw data from OpGen's financial statements into concise, actionable information that can be used to evaluate the performance of OpGen over time and compare it to other companies across industries.

OpGen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining OpGen's current stock value. Our valuation model uses many indicators to compare OpGen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OpGen competition to find correlations between indicators driving OpGen's intrinsic value. More Info.OpGen Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value OpGen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OpGen's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

If you are still planning to invest in OpGen Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OpGen's history and understand the potential risks before investing.